COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 829: Articles 8281-8290  | Next

ACE2 nanoparticles prevent cell entry of SARS-CoV-2
Sauvanet, C., Lemos, M., Bezault, A., Rodriguez de Francisco, B., Chan, M. C., Hui, K. P., Ng, K.-c., Nicholls, J. M., Volkmann, N., Hanein, D.
10.1101/2022.05.05.490805 — Posted: 2022-05-06
Protection against omicron severe disease 0-7 months after BNT162b2 booster
Amir, O., Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., Milo, R.
10.1101/2022.05.04.22274647 — Posted: 2022-05-05
The spread and burden of the COVID-19 pandemic in sub-Saharan Africa: comparison between predictions and actual data and lessons learned.
Fokoua-Maxime, C. D., Bellouche, Y., Tchigui-Ariolle, D. N., Tchato-Yann, T. L., Choukem, S. P.
10.1101/2022.05.04.22274692 — Posted: 2022-05-05
Optimal thromboprophylaxis strategies in non-critically ill patients with COVID-19 pneumonia. The PROTHROMCOVID Randomized Controlled Trial.
Munoz-Rivas, N., Aibar, J., Gabara-Xanco, C., Trueba-Vicente, A., Urbelz-Perez, A., Gomez-Del Olmo, V., Demelo-Rodriguez, P., Rivera-Gallego, A., Bosch-Nicolau, P., Perez-Pinar, M., Rios-Prego, M., Madridano-Cobo, O., Ramos-Alonso, L., Alonso-Carrillo, J., Francisco-Albelsa, I., Marti-Saez, E., Maestre-Peiro, A., Mendez-Bailon, M., Hernandez-Rivas, J. A., Torres-Macho, J.
10.1101/2022.05.03.22274594 — Posted: 2022-05-05
Net-shaped DNA nanostructure designed for rapid/sensitive detection and potential inhibition of SARS-CoV-2 virus
Chauhan, N., Xiong, Y., Ren, S., Dwivedy, A., Magazine, N., Zhou, L., Lin, X., Zhang, T., Cunningham, B. T., Yao, S., Huang, W., Wang, X.
10.1101/2022.05.04.490692 — Posted: 2022-05-05
Development and evaluation of low-volume tests to detect and characterise antibodies to SARS-CoV-2
Halliday, A., Long, A. E., Baum, H. E., Thomas, A. C., Shelley, K. L., Oliver, E., Gupta, K., Francis, O., Kavanagh Williamson, M., Di Bartolo, N., Randell, M. J., Ben Khoud, Y., Kelland, I., Mortimer, G., Ball, O., Plumptre, C., Chandler, K., Obst, U., Secchi, M., Piemonti, L., Lampasona, V., Smith, J., Gregorova, M., Knezevic, L., Metz, J., Barr, R., Morales-Aza, B., Oliver, J., Collingwood, L., Hitchings, B., Ring, S., Wooldridge, L., Rivino, L., Timpson, N. J., McKernon, J., Muir, P., Hamilton, F. W., Arnold, D., Woolfson, D. N., Goenka, A., Davidson, A. D., Toye, A. M., Berger, I., Bailey, M., Gillespie, K. M., Williams, A. J., Finn, A.
10.1101/2022.05.03.22274395 — Posted: 2022-05-05
SARS-CoV-2 neutralizing antibodies in Chile after a vaccination campaign with five different schemes
Aguilera, X., Hormazabal, J., Vial, C., Cortes, L. J., Gonzalez, C. W., Rubilar, P., Apablaza, M., Ramirez-Santana, M., Icaza, G., Nunez-Franz, L., Castillo-Laborde, C., Ramirez-Riffo, C., Perez, C., Quezada-Gaete, R., Said, M., Vial, P.
10.1101/2022.05.03.22274622 — Posted: 2022-05-05
Antibody responses to AZD1222 vaccination in West Africa
Abdullahi, A., Oladele, D., Kemp, S., Ayorinde, J., Salako, A., Ige, F., Fink, D., Onwuamah, C., Osuolale, Q., Abubakar, R., Okuruawe, A., Liboro, G., Odubela, O., Ohihoin, G., Ezechi, O., Usman, O., Mogaji, S., Dada, A., Ebrahimi, S., Gutierrez, L. C., Aliyu, S. H., Doffinger, R., Audu, R., Adegbola, R., Mlcochova, P., Salako, B. L., Gupta, R. K.
10.1101/2022.05.04.22274668 — Posted: 2022-05-05
Durability of the immune response to a third BNT162b2 dose; five months follow-up
Gilboa, M., Regev-Yochay, G., Mandelboim, M., Indenbaum, V., Asraf, K., Fluss, R., Amit, S., Mendelson, E., Doolman, R., Afek, A., Freedman, L., Kreiss, Y., Lustig, Y.
10.1101/2022.05.03.22274592 — Posted: 2022-05-05
Have infection control and prevention measures resulted in any adverse outcomes for care home and domiciliary care residents and staff?
Spencer, L. H., Hartfiel, N., Hendry, A., Anthony, B. F., Makanjuola, A., Bray, N., Hughes, D. A., Wilkinson, C., Fitzsimmons, D., Edwards, R. T.
10.1101/2022.05.04.22274657 — Posted: 2022-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).